SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: software salesperson who wrote (197)2/23/1999 6:57:00 PM
From: scaram(o)uche  Read Replies (2) of 3158
 
Sure.... I consider MLNM to be one of the top four drug discovery engines in the world, and the milestones keep rolling out to complement the Bayer deal.

Had the op to visit recently with Jim Silverman and to get, among other detailed peeks, a look at proteomics. Good stuff. Review the MLNM thread for more comments.

BTW.... I am going to cut down on responding to S.I. members who do not provide their names and/or backgrounds. Pseudonyms are great if you have a vested interest to protect and yet share background and wisdom.... e.g., Pseudo Biologist or Tommysdad. Otherwise, I find that anonymity just provides an op for cheap shots.

If you've reviewed the MLNM thread, then you need not ask questions in such an open-ended fashion. Drug development costs money, and the infrastructure and patents required to do such are valuable. One places their own personal value on them. I look at biologicals that do $1 billion/year and pharmaceuticals that do better, and see a market cap of $1.3 billion as a pittance.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News